Revlon Fails to Ensure Some Products Are Safe, FDA Warns (2)

June 9, 2026, 9:53 PM UTC

Revlon Group Holdings LLC didn’t properly test products for cancer-causing chemicals or mold, US regulators warned the beauty giant in a letter posted Tuesday.

The Food and Drug Administration called one Revlon product higher risk because of its potential to be contaminated with a known human carcinogen in the letter dated June 2. The details of the product and the potential contaminant were redacted from the public version of the letter.

Revlon didn’t respond to requests for comment.

Revlon told the FDA that its supplier analyzed product components, though the agency said Revlon had not verified the suppliers’ test methods ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.